-
公开(公告)号:US10799492B2
公开(公告)日:2020-10-13
申请号:US16133192
申请日:2018-09-17
Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
Inventor: Clas Sonesson
IPC: A61K31/451 , C07D211/24 , C07D211/32 , C07B59/00
Abstract: The present invention provides novel deuterated analogs of Pridopidine, i.e. 4-(3-methanesulfonyl-phenyl)-1-propyl-piperidine. Pridopidine is a drug substance currently in clinical development for the treatment of Huntington's disease.In other aspects the invention relates to pharmaceutical compositions comprising a deuterated analog of Pridopidine of the invention, and to therapeutic applications of these analogs.